Integra Lifesciences Holdings Corp (IART) reports robust adjusted EPS growth and strategic product relaunches, despite facing supply chain disruptions and revised guidance.
In the final part of our series on the inner workings of the national selection panel, we explore 27 months of deliberations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback